These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37982062)
21. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation. Kesavadev J; Vigersky R; Shin J; Pillai PBS; Shankar A; Sanal G; Krishnan G; Jothydev S Adv Ther; 2017 Aug; 34(8):1918-1927. PubMed ID: 28667580 [TBL] [Abstract][Full Text] [Related]
22. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
23. A Team-Based Training for Continuous Glucose Monitoring in Diabetes Care: Mixed Methods Pilot Implementation Study in Primary Care Practices. Filippi MK; Oser SM; Alai J; Brooks-Greisen A; Oser TK JMIR Form Res; 2023 Apr; 7():e45189. PubMed ID: 37093632 [TBL] [Abstract][Full Text] [Related]
24. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring. Telo GH; Volkening LK; Butler DA; Laffel LM Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206 [TBL] [Abstract][Full Text] [Related]
25. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology. Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603 [TBL] [Abstract][Full Text] [Related]
26. Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology. Galindo RJ; Aleppo G Diabetes Res Clin Pract; 2020 Dec; 170():108502. PubMed ID: 33065179 [TBL] [Abstract][Full Text] [Related]
27. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial. Klarskov CK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL Trials; 2020 Nov; 21(1):968. PubMed ID: 33239100 [TBL] [Abstract][Full Text] [Related]
28. The Effectiveness of Continuous Glucose Monitoring Devices in Managing Uncontrolled Diabetes Mellitus: A Retrospective Study. Manov AE; Chauhan S; Dhillon G; Dhaliwal A; Antonio S; Donepudi A; Jalal YN; Nazha J; Banal M; House J Cureus; 2023 Jul; 15(7):e42545. PubMed ID: 37637581 [TBL] [Abstract][Full Text] [Related]
30. Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. DeSalvo DJ; Lanzinger S; Noor N; Steigleder-Schweiger C; Ebekozien O; Sengbusch SV; Yayah Jones NH; Laubner K; Maahs DM; Holl RW Diabetes Technol Ther; 2022 Dec; 24(12):920-924. PubMed ID: 35947079 [TBL] [Abstract][Full Text] [Related]
31. Glycemic variability and indices of glycemic control among pregnant women with type 1 diabetes (T1D) based on the use of continuous glucose monitoring share technology. Sklar J; Pyle L; Snell-Bergeon JK; Garcetti R; Joshee P; Demmitt JK; Polsky S J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8968-8974. PubMed ID: 34875947 [TBL] [Abstract][Full Text] [Related]
32. Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes. McGill DE; Volkening LK; Butler DA; Harrington KR; Katz ML; Laffel LM Diabetes Technol Ther; 2018 Jun; 20(6):434-439. PubMed ID: 29727245 [TBL] [Abstract][Full Text] [Related]
33. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes. Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413 [TBL] [Abstract][Full Text] [Related]
34. Roadmap to the Effective Use of Continuous Glucose Monitoring by Diabetes Care and Education Specialists as Technology Champions. Albanese-O'Neill A Diabetes Spectr; 2023; 36(4):288-298. PubMed ID: 37982064 [TBL] [Abstract][Full Text] [Related]
36. Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine. Cobry EC; Reznick-Lipina T; Pyle L; Slover R; Thomas JF; Alonso GT; Wadwa RP Diabetes Technol Ther; 2022 Jan; 24(1):67-74. PubMed ID: 34524007 [No Abstract] [Full Text] [Related]
37. Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties. Rasbach LE; Volkening LK; Markowitz JT; Butler DA; Katz ML; Laffel LM Diabetes Technol Ther; 2015 May; 17(5):327-34. PubMed ID: 25695341 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus. Gurnurkar S; Owens L; Chalise S; Vyas N J Pediatr Endocrinol Metab; 2021 Mar; 34(3):311-317. PubMed ID: 33618445 [TBL] [Abstract][Full Text] [Related]
39. Applying the use of shared medical appointments (SMAs) to improve continuous glucose monitor (CGM) use, glycemic control, and quality of life in marginalized youth with type 1 diabetes: Study protocol for a pilot prospective cohort study. Grundman JB; Majidi S; Perkins A; Streisand R; Monaghan M; Marks BE Contemp Clin Trials Commun; 2023 Apr; 32():101067. PubMed ID: 36698741 [TBL] [Abstract][Full Text] [Related]
40. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. Golden SH; Sapir T J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]